Instead, buyers must look for concrete operational transparency: verifiable purity reports, responsive local support, and logistics networks designed specifically for the Middle Eastern climate
Also, kindly note that the company profile section include both companies that have commercial drug available in market as well as those that are into clinical phase development
The inclusion of younger patients, who are at very low risk for NAION, likely dilutes the true hazard ratio for semaglutide in the older population, who are the primary recipients of this therapy
Theres biological rationale that GLP-1 RAs may have neuroprotective effects (they reduce inflammation, improve insulin signaling in the brain, etc.)
Not for medical, therapeutic, or diagnostic use.